20 mg bpc 157 BPC-157 + TB-500 20mg Blend TB-500 / BPC-157 20mg |

Standard Therapeutic Cycle (12 Weeks): Clinical trials frequently employed 12-week protocols, which provide sufficient duration for measurable metabolic changes while establishing safety through comprehensive monitoring

Animal models exposed to 5-Amino-1MQ demonstrate accelerated lipid metabolism and extensive white adipose tissue remodelling, driven by up-regulated SIRT1 activity

Before starting, confirm with your healthcare provider that self-administration is appropriate for you

The dose and duration depend on individual nutritional status, response to treatment, and ongoing clinical evaluation

Much of the current evidence is preclinical (cell and animal studies), and human data is still limited